PLAINSBORO, N.J. From leveraging their joint buying power to better deployment of a hard-to-find pediatric liver transplant surgeon, two large healthcare systems in Florida are seeing the benefits of sharing resources on a bigger scale, according to Kavita Patel, MD, of the Brookings Institution, and her co-authors who write in the inaugural issue of The American Journal of Accountable Care.
FOR IMMEDIATE RELEASE DECEMBER 17, 2013
Florida Healthcare Collaborative Offers Road Map For Creating Partnerships to Contain Costs
Brookings’ Dr. Kavita Patel Offers Insights in AJAC
PLAINSBORO, N.J. From leveraging their joint buying power to better deployment of a hard-to-find pediatric liver transplant surgeon, two large healthcare systems in Florida are seeing the benefits of sharing resources on a bigger scale, according to Kavita Patel, MD, of the Brookings Institution, and her co-authors who write in the inaugural issue of The American Journal of Accountable Care.
Patel examines the early returns of a 2010 decision to collaborate in both clincial and governance realms by the University of Florida and Shands, a $2.7 billion enterprise of the University of Florida Academic Health Center and Shands Teaching Hospital and Clinics, and Orlando Health Inc., a $2 billion not-for-profit corporation. The process, which paved the way for a regional accountable care organization (ACO), showed how the these major healthcare providers were able to achieve “millions of dollars” in savings while providing better care for patients. Click here to read the article, “Collaborative Care Before Accountable Care: Achieving Low-Cost, High-Quality Care Through a Regional Collaborative in Florida.”
Geographically, the collaborative stretches from Orlando, in central Florida, all the way to Jacksonsville, on the state’s Atlantic Coast near the Georgia border. That much territory, and access to more than 3 million residents, allowed for collaboration in four major areas: clinical integration, data anlalytics, contracting and operations. As Patel writes, the clinical opportunities were pursued first; other projects came in a second phase.
For each healthcare group, collaboration demanded honesty about its own strengths and weaknesses — and trust. “An expressed intent of these programs is the transparent sharing of data to critically evaluate which system has the best program in order to learn from each other and not duplicate costly services in which regional volumes are low,” Patel writes.
But for patients, the payoffs were worth it. Success stories in clinical areas include:
In the nonclinical areas, the immediate benefits are seen in purchasing savings in both healthcare groups, Patel writes. “Early results of supply chain analysis indicate millions in savings for both organizations,” the article states.
Patel concludes, “We believe that the innovative approach taken by the University of Florida and Shands and Orlando Health has produced not only short-term benefits for both organizations, but also a viable path for transitioning to a more accountable payment and delivery model througha formal ACO contract in the future.”
FOR INFORMATION CONTACT: Nicole Beagin, Associate Editorial Director
(609) 716-7777 x 131
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More
MRI, sIL-2R Combination Showcases Great Diagnostic Accuracy for Soft Tissue NHL
January 27th 2025Serum soluble interleukin-2 receptor (sIL-2R) levels have been a great diagnostic tool for non-Hodgkin lymphoma (NHL) and could provide further benefits for distinguishing soft-tissue NHL from other soft tissue tumors.
Read More
Unlocking Early Colorectal Cancer Detection With Artificial Intelligence
January 23rd 2025With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.
Read More